Sarepta Therapeutics Drops on Fake Citron Tweet
January 30, 2013 - 11:37am
Shares of Sarepta Therapeutics (NASDAQ: SRPT) dropped briefly on Wednesday, giving back all their gains on the session, after a tweet from a twitter account called @citronresearc.
The tweet states: "$SRPT FDA steps in as its 48 weeks results on Eteplirsen results are ...
Continue reading this article »
Share This Article: